C. Blank et al., A novel high mobility group protein gene is a candidate for Xp22 abnormalities in uterine leiomyomas and other benign tumors, CANC GENET, 121(2), 2000, pp. 172-180
Because genes of the high mobility group protein family HMGI(Y) are known t
o take part in the development of a variety of benign solid tumors, the aim
of the present study It as to search for further members of that family in
the human genome. Analysis for HMGI(Y)-related sequences by the polymerase
chain reaction (PCR) with the use of cDNA-specific primers offered evidenc
e for HMGIY-like sequences, whereas HMGIC-related sequences were apparently
absent. By chromosomal assignment of somatic cell hybrids PCR, HMGIY cDNA-
related sequences Mere detected on seven chromosomes. Positive clones were
obtained by screening of a PI-derived artificial chromosome library and map
ped by fluorescence in situ hybridization. One of these clones assigned to
Xp22.1 was chosen for further analysis because Xp22 is a target region for
clonal aberrations in benign solid tumors. Sequence analysis of a DNA fragm
ent of this clone, designated as HMGIYL1, revealed a 94.4% homology to the
coding region of HMGIY. Within the HMGIYL1 sequence, no nucleotide sequence
divergences leading to a frame shift or a new termination codon compared t
o HMGIY were found, and a TATA-box-like motif 5' of if was detected. By rev
erse transcriptase PCR experiments with the use of HeLa cells and human fet
al tissue, HMGIYL1 expression was not detectable. Nevertheless, if not acti
ve by itself, it is possible that HMGIYL1 may become activated by chromosom
al rearrangements of Xp22 observed in benign solid tumors. (C) 2000 Elsevie
r Science Inc. All rights reserved.